CD69
EARLY ACTIVATION ANTIGEN (EA-1)
Clone & Isotype | Conjugate | Size | Format | Line | | Part Number |
|
TP1.55.3 | Purified | 0.2 mg | Freeze-dried | | | IM0780 |
IgG2b (mouse) | PE | 100 tests | Liquid | IOTest | | IM1943 |
| PE-Cy5 | 100 tests | Liquid | IOTest | | IM2079 |
|
|
The CD69 antigen is a 60 kDa disulfide-linked dimeric structure, known as Activation Inducer Molecule (AIM). This structure contains two differentially glycosylated forms (33 and 27 kDa) of a single core protein. This activation antigen is the earliest appearing cell surface glycoprotein (before other activation antigens such as IL2-R) after T or B cell activation but is absent in resting lymphocytes. It is also expressed by activated macrophages, by Natural Killer (NK) cells and by other cell types including neutrophils, eosinophils and platelets . Its expression in vitro can be induced by different factors such as PMA, PHA or CD3 monoclonal antibodies. CD69 antibody is useful in combination with CD4, CD8 and CD3 antibodies for T cell activation studies. TP1.55.3 antibody immunoprecipitates the 60 kDa homodimer and both 27 kDa and 33 kDa subunits from activated peripheral blood lymphocytes under reduced and non-reduced conditions. This antibody was evaluated during the Fourth International Workshop on Human Leukocyte Differentiation Antigens.

© Coulter International Corporation, 1996. All rights reserved. Copyrights and Trademarks
Products are available FOR RESEARCH USE ONLY (RUO). Unless indicaed FOR IN VITRO DIAGNOSTIC USE (IVD)
CD ROM Vol 2 was produced by staff at the Purdue University Cytometry Laboratories
and distributed free of charge as an educational service to the cytometry community.
If you have any comments please direct them to Dr. J. Paul Robinson, Professor & Director, PUCL,
Purdue University, West Lafayette, IN 47907. Phone:(317) 494-0757; FAX (317) 494-0517; Web http://www.cyto.purdue.edu
EMAIL robinson@flowcyt.cyto.purdue.edu